Viromed Medical Secures Government Backing for Plasma Technology Development
Shares of Viromed Medical (VIROMED MEDICAL) continue to trade near their annual low at €5.20, despite the company receiving a...
Shares of Viromed Medical (VIROMED MEDICAL) continue to trade near their annual low at €5.20, despite the company receiving a...
While Nvidia continues to post staggering financial results, a persistent shadow of trade policy uncertainty hangs over the semiconductor giant....
The iShares MSCI World ETF (URTH) is navigating a period of intensified competition and impending structural change. As a core...
The data analytics firm Palantir continues to post impressive operational growth, yet on Wall Street, skepticism is mounting over its...
Despite reports of a multi-billion dollar budget for its next major title, Take-Two Interactive Software Inc. is seeing its stock...
The biotechnology firm ImmunityBio finds itself caught between significant operational progress and mounting regulatory scrutiny. A recent official warning from...
Pharmaceutical giant Eli Lilly is strategically expanding its empire beyond its blockbuster weight-loss drugs. In a series of moves totaling...
Amazon is passing on rising operational costs to the third-party merchants using its platform. Effective April 17, a new fuel...
The digital payments landscape is on the cusp of a profound transformation, and Visa is positioning itself at the center...
Global Atomic Corporation is ramping up development activities at its Dasa uranium project in Niger. The company has transitioned from...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com